HEM Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| HEM1036 Phase 2 Study in Low Anterior Resection Syndrome (NCT05527301) | HEM Pharma Inc. | 2024-01-01 |
Track HEM Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.